This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Figure 10: Organization of Thalidomide Efficacy Tables
| |
Newly diagnosed/previously untreated multiple myeloma |
Advanced/refractory/resistant multiple myeloma |
Thalidomide only |
Table 2 |
Table 3 |
Thalidomide plus dexamethasone |
Table 4 |
Table 5 |
Thalidomide plus other agents |
Table 6 |
Table 7 |
Thalidomide pre- or post-SCT |
Table 8 |
Return to Document